Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Genprex, Inc.

Equities

GNPX

US3724462037

Real-time Estimate Cboe BZX
Other stock markets
 11:07:43 2024-06-03 EDT 		5-day change 1st Jan Change
3.24 USD +4.18% Intraday chart for Genprex, Inc. +53.44% -64.64%
05-15 Genprex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENPREX, INC.
Bio Therapeutic Drugs
+4.60%+53.44%-64.64%-91.42%-94.75% 6.52M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Charts Genprex, Inc.
  5. Relative Strength Chart